Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 37.762% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: CC(=O)c1cn(-c2ccc(Cl)cc2)c(=O)n(Cc2ccc(F)cc2)c1=O
b: Brc1ccc(N/N=C(/N=Nc2nn[nH]n2)c2ccccc2)cc1
c: N#CC1=C(N)C2=CCCC[C@H]2[C@H](c2ccccc2)C1(C#N)C#N
d: Cl.O=C(O)c1ccc(OCCn2ccnc2)cc1
e: CCOC(=O)c1ccc(NC(=O)COC(=O)Cc2csc(-c3ccccc3)n2)cc1
Answer: b. Brc1ccc(N/N=C(/N=Nc2nn[nH]n2)c2ccccc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Brc1ccc(N/N=C(/N=Nc2nn[nH]n2)c2ccccc2)cc1
Brc1ccc(N/N=C(/N=Nc2nn[nH]n2)c2ccccc2)cc1
N'-(4-bromoanilino)-N-(2H-tetrazol-5-ylimino)benzenecarboximidamide